Bleakley Financial Group LLC Boosts Stock Position in Danaher Corporation $DHR

Key Points

• Bleakley Financial Group LLC increased its stake in Danaher Corporation by 36.4% in Q2, owning 27,938 shares valued at $5,519,000.
• Danaher reported $6.05 billion in revenue for the recent quarter, surpassing analyst expectations and showing a 4.4% year-over-year increase.
• The company declared a quarterly dividend of $0.32, resulting in an annual yield of 0.6% and a dividend payout ratio of 27.23%.

Bleakley Financial Group LLC increased its position in Danaher Corporation (NYSE:DHR - Free Report) by 36.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,938 shares of the conglomerate's stock after acquiring an additional 7,461 shares during the quarter. Bleakley Financial Group LLC's holdings in Danaher were worth $5,519,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Nuveen LLC purchased a new stake in shares of Danaher in the first quarter worth $833,941,000. Invesco Ltd. increased its stake in Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after buying an additional 1,450,703 shares in the last quarter. Baird Financial Group Inc. raised its holdings in Danaher by 290.6% during the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate's stock valued at $295,550,000 after acquiring an additional 1,072,617 shares during the period. Generation Investment Management LLP lifted its position in shares of Danaher by 33.2% in the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate's stock valued at $651,515,000 after acquiring an additional 791,662 shares in the last quarter. Finally, Parnassus Investments LLC boosted its stake in shares of Danaher by 23.3% in the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate's stock worth $784,745,000 after acquiring an additional 722,636 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

Shares of NYSE:DHR opened at $222.62 on Friday. The firm has a fifty day simple moving average of $202.49 and a two-hundred day simple moving average of $198.02. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The company has a quick ratio of 1.22, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $157.25 billion, a P/E ratio of 45.90, a PEG ratio of 3.31 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the business posted $1.71 earnings per share. The firm's revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's dividend payout ratio (DPR) is currently 27.23%.

Insiders Place Their Bets

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 11.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on DHR. Barclays lifted their target price on Danaher from $225.00 to $250.00 and gave the company an "overweight" rating in a research note on Wednesday. Wells Fargo & Company reiterated a "positive" rating on shares of Danaher in a research report on Thursday. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a research report on Friday, July 11th. Robert W. Baird set a $247.00 target price on shares of Danaher in a research note on Wednesday. Finally, Evercore ISI boosted their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 7th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.